A LoGiCal® success for online SPE-LC/MSMS
Publication date: 27 November 2012
Author: kdm communications limited
Tagged with: LGC Standards, Martin Sibum, Spark Holland
LoGiCal® reference materials from LGC Standards have enabled specialist instrument manufacturer Spark Holland in Emmen, the Netherlands, to establish an online SPE-LC/MSMS method for the analysis of synthetic cannabinoids.
Martin Sibum, Business Development Manager at Spark Holland
Business Development Manager Martin Sibum explained: “We develop applications for a variety of markets, including clinical pharma, toxicology and forensics, and are involved in screening for drugs of abuse. The use of designer drugs is on the increase, and we needed to develop a quantitative online SPE-LC/MSMS method for the analysis of synthetic cannabinoids, or ‘Spice’ compounds. These compounds are relatively new, and LGC Standards was quite unique in being able to supply reference standards for five Spice compounds from stock.”
“Availability of these reference materials allowed us to quickly and easily prepare calibration standards for each compound, and to develop an automated SPE method on a Symbiosis™ system. Within two days, we had established an online SPE-LC/MSMS method1 for the quantification of five Spice compounds in urine. This was the first time we had worked with LGC Standards, and we achieved excellent results using LoGiCal reference materials. CVs were less than 5 % – and accuracy within ±10 % – for all compounds and concentrations, with correlation coefficients greater than 0.99. LGC Standards was really helpful and showed an interested in the results, so it was an excellent first collaboration.”
To learn more about the LoGiCal product range, visit www.logical-standards.com
Reference
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Novartis wins GBCHealth Business Action on Health Award for social ventures initiative (17 May 2013)
- Could a ‘super computer’ help improve epilepsy care? Yes, it’s elementary my dear WATSON (16 May 2013)
- Promising new data demonstrate that a novel pain therapy system manages patients with chronic neuropathic pain (16 May 2013)
- Roche’s obinutuzumab significantly reduced the risk of disease progression or death in people with one of the most common forms of blood cancer (16 May 2013)
- AstraZeneca issues update on accelerated oncology pipeline in advance of 2013 ASCO Annual Meeting (16 May 2013)
Mass Spectrometry: In-depth focus
This free to view Mass Spectrometry in-depth focus features articles from experts at University of British Columbia and University of Colorado Denver.
Stem Cells: In-depth focus
This free to view Stem Cells in-depth focus features articles from experts at Max Planck Institute for Molecular Genetics, Heinrich Heine University and Newcastle University.
Company directory
ABB Analytical Measurements | Analytik Jena AG | Aptalis Pharmaceutical Technologies | ASM - Aerosl-Service AG | Azbil BioVigilant, Inc. | B&W Tek, Inc. | Bio-Optronics, Inc. | bioMérieux | BioTrends – Archilex SA | BMG LABTECH GmbH | Bruker Daltonik GmbH | CAMO Software AS | Catalent Pharma Solutions | Chemical Plant Equipment | Chemspec Europe Ltd | CI Precision | Dow Chemical Company Ltd | DSM Biologics | FOSS NIRSystems, Inc. | GE Analytical Instruments | GenScript USA Inc. | Gerresheimer Group | HACH LANGE GMBH | HAMAMATSU PHOTONICS EUROPE | I Holland Limited | IDBS | IONIMED Analytik GmbH | Lonza | MPI Research | Natoli Engineering Company, Inc. | PANalytical B.V. | Patheon Inc | ReAgent | Roche | Siemens AG | Sirius Analytical Instruments Ltd | TSI | Waters Corporation |
Login to access exclusive content